J&J Settles Five Cases After Former FDA Chief Says It Illegally Marketed Risperdal for Children


Former FDA Commissioner David Kessler testified in an “Expert Report” submitted for a trial set to begin Oct. 9 that “(Johnson & Johnson subsidiary) Janssen’s promotion of Risperdal, a powerful drug, for non-approved uses in the most vulnerable children is deeply troubling.” J&J’s lawyers had attempted to prevent Kessler’s testimony on procedural grounds, but following the submission of his report J&J settled out-of-court with five plaintiffs this morning. When asked if the prospect of Kessler’s testimony motivated J&J to settle, plaintiffs’ attorney Stephen Sheller said, “Yes.”

Article → 
Of Further Interest:
J&J aims to block ex-FDA chief’s testimony in Risperdal case (Fierce Pharma)
Former FDA Commish Slams J&J Over Risperdal (Pharmalot)
Expert Report by David Kessler, M.D. (Part 1)
Expert Report by David Kessler, M.D. (Part 2)
Expert Report by David Kessler, M.D. (Part 3)
Expert Report by David Kessler, M.D. (Part 4) 

Previous articleDr. Friedman Criticizes the Overuse of the Atypical Antipsychotics
Next articleHealing Voices Film
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].